Phase IIB TL + YCWP + DC in Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George E Peoples, MD
LumaBridge
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Birmingham (uab) Comprehensive Cancer Center
Birmingham, Alabama, United States
- Mayo Clinic - Cancer Clinical Research Office
Phoenix, Arizona, United States
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- the Angeles Clinic and Research Institute A Cedars-Sinai Affiliate
Los Angeles, California, United States
- John Wayne Cancer Institute
Santa Monica, California, United States
- Mount Sinai Cancer Research Program
Miami Beach, Florida, United States
- Northside Hospital Cancer Institute
Atlanta, Georgia, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Mayo Clinic, Rochester
Rochester, Minnesota, United States
- New Mexico Cancer Care Alliance
Albuquerque, New Mexico, United States
- Laura and Isaac Permutter Cancer Center @ Nyu Langone
New York, New York, United States
- University of Cincinnati Cancer Institute
Cincinnati, Ohio, United States
- the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- St. Francis Hospital Cancer Center
Greenville, South Carolina, United States
- Huntsman Cancer Institute/the University of Utah
Salt Lake City, Utah, United States
- Providence Regional Medical Center Everett
Everett, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 11 May 2022
- Completion
- 11 May 2022
- Last update posted
- 29 Nov 2024
- Registered enrollment
- 187
- Registry id
- NCT02301611
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.